Citigroup’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-736,406
| Closed | -$832K | – | 5872 |
|
|
2022
Q2 | $832K | Buy |
736,406
+736,239
| +440,862% | +$832K | ﹤0.01% | 2218 |
|
|
2022
Q1 | $1K | Buy |
+167
| New | +$1K | ﹤0.01% | 5426 |
|
|
2021
Q3 | – | Sell |
-67
| Closed | -$1K | – | 5684 |
|
|
2021
Q2 | $1K | Sell |
67
-5,169
| -99% | -$77.1K | ﹤0.01% | 5393 |
|
|
2021
Q1 | $137K | Buy |
5,236
+4,262
| +438% | +$112K | ﹤0.01% | 3565 |
|
|
2020
Q4 | $35K | Buy |
974
+668
| +218% | +$24K | ﹤0.01% | 4320 |
|
|
2020
Q3 | $11K | Sell |
306
-222
| -42% | -$7.98K | ﹤0.01% | 4282 |
|
|
2020
Q2 | $22K | Buy |
528
+260
| +97% | +$10.8K | ﹤0.01% | 4205 |
|
|
2020
Q1 | $21K | Buy |
268
+79
| +42% | +$6.19K | ﹤0.01% | 4348 |
|
|
2019
Q4 | $18K | Buy |
189
+90
| +91% | +$8.57K | ﹤0.01% | 4534 |
|
|
2019
Q3 | $8K | Sell |
99
-164
| -62% | -$13.3K | ﹤0.01% | 4665 |
|
|
2019
Q2 | $26K | Buy |
+263
| New | +$26K | ﹤0.01% | 4469 |
|
|
2016
Q2 | – | Sell |
-1
| Closed | – | – | 5402 |
|
|
2016
Q1 | $0 | Buy |
+1
| New | – | ﹤0.01% | 5709 |
|